Shionogi & Co., Ltd. (SGIOF)

OTCMKTS · Delayed Price · Currency is USD

12.28

+0.07 (0.57%)

At close: Jan 2, 2025

Shionogi & Employees

Shionogi & had 4,959 employees as of March 31, 2024. The number of employees decreased by 721 or -12.69% compared to the previous year.

Employees

4,959

Change (1Y)

-721

Growth (1Y)

-12.69%

Revenue / Employee

$589,081

Profits / Employee

$217,568

Market Cap

11.95B

Employees Chart

Employees History

Date	Employees	Change	Growth
Mar 31, 2024	4,959	-721	-12.69%
Mar 31, 2023	5,680	-13	-0.23%
Mar 31, 2022	5,693	208	3.79%
Mar 31, 2021	5,485	263	5.04%
Mar 31, 2020	5,222	-11	-0.21%
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro
Mar 31, 2015	Pro	Pro	Pro

Related Stocks

Company Name	Employees
Endo Inc.	2,931
Elite Pharmaceuticals	64
Glass House Brands	413
Northwest Biotherapeutics	25
Silence Therapeutics	109
SANUWAVE Health	31

Employee Rankings

Shionogi & News

2 months ago - Shionogi & Co., Ltd. (SGIOY) Q2 2024 Earnings Call Transcript - Seeking Alpha
4 months ago - Antibiotics, an important but tricky business, says Shionogi CEO [Advocacy Lab Content] - EURACTIV.com
6 months ago - Shionogi & Co., Ltd. (SGIOY) Q1 2024 Earnings Call Transcript - Seeking Alpha
8 months ago - Shionogi & Co., Ltd. and Maze Therapeutics, Inc. Announce Exclusive Worldwide License Agreement for MZE001, a Novel Therapeutic Candidate for the Treatment of Pompe Disease - Business Wire
1 year ago - Shionogi & Co., Ltd. (SGIOF) Q2 2023 Earnings Conference Call Transcript - Seeking Alpha
1 year ago - Shionogi & Co., Ltd. (SGIOF) Q1 2023 Earnings Call Transcript - Seeking Alpha
2 years ago - Shionogi: Likely The Last Viable COVID Play - Seeking Alpha
2 years ago - Shionogi & Co., Ltd. (SGIOF) Q3 2022 Earnings Call Transcript - Seeking Alpha